Specifically, EA was shown to alleviate visceral hyperalgesia and anxiety in a TNBS-treated mouse model of IBD; EA reversed the overexpression of CB1R in a mouse model of IBD and reduced the expression of GABAergic neurons in the CB1R in the vHPC. This evidence concerns the gene CNR1 and irritable bowel syndrome.